✦ LIBER ✦

Combined therapy of mixed dyslipidemia in patients with high cardiovascular risk and changes in the lipid target values and atherogenic index of plasma

✍ Scribed by Rosolova, Hana; Dobiasova, Milada; Soska, Vladimir; Blaha, Vladimir; Ceska, Richard; Nussbaumerova, Barbora; Pelikanova, Terezie; Soucek, Miroslav

Book ID: 123299993
Publisher: Czech Society of Cardiology
Year: 2014
Tongue: English
Weight: 348 KB
Volume: 56
Category: Article
ISSN: 0010-8650
DOI: 10.1016/j.crvasa.2014.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with the Combination of Niacin

Treatment with the Combination of Niacin Extended-Release and Simvastatin Reduces Atherogenic Particles in Patients with Mixed Dyslipidemia

✍ Richard H. Karas; Moti L. Kashyap; Michael H. Davidson; Roopal B. Thakkar; Ping 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 191 KB

98 TARGET LIPID LEVELS AND RESERVES IN H

98 TARGET LIPID LEVELS AND RESERVES IN HYPOLIPIDEMIC THERAPY IN THE PATIENTS AT VERY HIGH RISK OF CARDIOVASCULAR EVENTS

✍ Petrus, J.; Málek, F.; Dvořák, J.; Skalníková, V.; Neužil, P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Cross-Sectional Survey to Assess the Sta

Cross-Sectional Survey to Assess the Status of Lipid Management in High-Risk Patients With Dyslipidemia: Clinical Impact of Combination Therapy With Ezetimibe

✍ Tamio Teramoto; Atsunori Kashiwagi; Shun Ishibashi; Hiroyuki Daida 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 526 KB

Simultaneous Achievement of Optimal Lipi

Simultaneous Achievement of Optimal Lipid Levels with the Combination of Fenofibric Acid and Rosuvastatin in Patients with Mixed Dyslipidemia

✍ Michael H. Davidson; Peter H. Jones; Aditya Lele; Dawn M. Carlson; Carolyn M. Se 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 52 KB

Improvements in Lipid Ratios with the Co

Improvements in Lipid Ratios with the Combination of Rosuvastatin 5 mg and Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia

✍ Robert S. Rosenson; Maureen T. Kelly; Carolyn M. Setze; Alex Gold; Michael Cress 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 45 KB

Effects of combination therapy with rosu

Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥2 mg/L)

✍ Christie M. Ballantyne; Michael H. Davidson; Carolyn M. Setze; Maureen T. Kelly 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 274 KB